Cargando…
Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies
The atherothrombotic substrates for acute coronary syndromes (ACS) consist of plaque ruptures, erosions and calcified nodules, while the non-atherothrombotic etiologies, such as spontaneous coronary artery dissection, coronary artery spasm and coronary embolism are the rarer causes of ACS. The purpo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070089/ https://www.ncbi.nlm.nih.gov/pubmed/33920201 http://dx.doi.org/10.3390/cells10040865 |
_version_ | 1783683389022273536 |
---|---|
author | Khandkar, Chinmay Madhavan, Mahesh V. Weaver, James C. Celermajer, David S. Karimi Galougahi, Keyvan |
author_facet | Khandkar, Chinmay Madhavan, Mahesh V. Weaver, James C. Celermajer, David S. Karimi Galougahi, Keyvan |
author_sort | Khandkar, Chinmay |
collection | PubMed |
description | The atherothrombotic substrates for acute coronary syndromes (ACS) consist of plaque ruptures, erosions and calcified nodules, while the non-atherothrombotic etiologies, such as spontaneous coronary artery dissection, coronary artery spasm and coronary embolism are the rarer causes of ACS. The purpose of this comprehensive review is to (1) summarize the histopathologic insights into the atherothrombotic plaque subtypes in acute ACS from postmortem studies; (2) provide a brief overview of atherogenesis, while mainly focusing on the events that lead to plaque destabilization and disruption; (3) summarize mechanistic data from clinical studies that have used intravascular imaging, including high-resolution optical coherence tomography, to assess culprit plaque morphology and its underlying pathobiology, especially the newly described role of innate and adaptive immunity in ACS secondary to plaque erosion; (4) discuss the utility of intravascular imaging for effective treatment of patients presenting with ACS by percutaneous coronary intervention; and (5) discuss the opportunities that these mechanistic and imaging insights may provide for more individualized treatment of patients with ACS. |
format | Online Article Text |
id | pubmed-8070089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80700892021-04-26 Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies Khandkar, Chinmay Madhavan, Mahesh V. Weaver, James C. Celermajer, David S. Karimi Galougahi, Keyvan Cells Review The atherothrombotic substrates for acute coronary syndromes (ACS) consist of plaque ruptures, erosions and calcified nodules, while the non-atherothrombotic etiologies, such as spontaneous coronary artery dissection, coronary artery spasm and coronary embolism are the rarer causes of ACS. The purpose of this comprehensive review is to (1) summarize the histopathologic insights into the atherothrombotic plaque subtypes in acute ACS from postmortem studies; (2) provide a brief overview of atherogenesis, while mainly focusing on the events that lead to plaque destabilization and disruption; (3) summarize mechanistic data from clinical studies that have used intravascular imaging, including high-resolution optical coherence tomography, to assess culprit plaque morphology and its underlying pathobiology, especially the newly described role of innate and adaptive immunity in ACS secondary to plaque erosion; (4) discuss the utility of intravascular imaging for effective treatment of patients presenting with ACS by percutaneous coronary intervention; and (5) discuss the opportunities that these mechanistic and imaging insights may provide for more individualized treatment of patients with ACS. MDPI 2021-04-10 /pmc/articles/PMC8070089/ /pubmed/33920201 http://dx.doi.org/10.3390/cells10040865 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khandkar, Chinmay Madhavan, Mahesh V. Weaver, James C. Celermajer, David S. Karimi Galougahi, Keyvan Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title | Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title_full | Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title_fullStr | Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title_full_unstemmed | Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title_short | Atherothrombosis in Acute Coronary Syndromes—From Mechanistic Insights to Targeted Therapies |
title_sort | atherothrombosis in acute coronary syndromes—from mechanistic insights to targeted therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070089/ https://www.ncbi.nlm.nih.gov/pubmed/33920201 http://dx.doi.org/10.3390/cells10040865 |
work_keys_str_mv | AT khandkarchinmay atherothrombosisinacutecoronarysyndromesfrommechanisticinsightstotargetedtherapies AT madhavanmaheshv atherothrombosisinacutecoronarysyndromesfrommechanisticinsightstotargetedtherapies AT weaverjamesc atherothrombosisinacutecoronarysyndromesfrommechanisticinsightstotargetedtherapies AT celermajerdavids atherothrombosisinacutecoronarysyndromesfrommechanisticinsightstotargetedtherapies AT karimigalougahikeyvan atherothrombosisinacutecoronarysyndromesfrommechanisticinsightstotargetedtherapies |